L.E. DeLanney - Concepedia

Concepedia

Author

L.E. DeLanney

California Institute for Medical Research

Also Known As

L DeLanney, L E DeLanney, L E Delanney, L. DeLanney, L. E. DELANNEY, L. E. DeLanney, L. E. Delanney, L.E. DeLanney, L.E. Delanney, Louise E. Delanney

29

Publications

1.7K

Citations

19

H-Index

43

Concepts

All Affiliations

California Institute for Medical Research Stanford University Johns Hopkins University Johns Hopkins Medicine Parkinson's Institute and Clinical Center

LD

About

L.E. DeLanney is an author at California Institute for Medical Research specializing in medicine, neuroscience, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.5K
2	Social Sciences	12	13	1.2K
3	Neurology	8	8	959
4	Biochemistry	1	1	51
5	Metabolism	1	1	51

L.E. DeLanney

×

24

Publications

1.7K

Citations

19

H-Index

	Year	Citations
Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration G.A. Ricaurte, L.E. DeLanney, Ian Irwin, Brain Research Psychoactive DrugPsychiatryNeurophysiologyNeuroanatomyToxic Effects	1988	249
Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations. Lysia S. Forno, L.E. DeLanney, Ian Irwin, PubMed Primate SystematicsPeripheral Nervous SystemSocial SciencesNeurobiology Of DiseaseExperimental Neuropathology	1993	208
Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra G.A. Ricaurte, Ian Irwin, L.S. Forno, Brain Research 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced DegenerationSubstantia NigraDopaminergic NeuronsMedicineNeuropharmacology	1987	185
Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A neurochemical and morphological reassessment George A. Ricaurte, J. William Langston, L.E. DeLanney, Brain Research Developmental BiologyMolecular NeuroscienceYoung MatureNeuroanatomyNeurotransmitter	1986	180
Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Rosario Moratalla, Bruce Quinn, L.E. DeLanney, Proceedings of the National Academy of Sciences Dopaminergic MarkersDifferential VulnerabilityNeurotransmitterPsychopharmacologySocial Sciences	1992	151
Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum G.A. Ricaurte, J. William Langston, L.E. DeLanney, Neuroscience Letters Mouse StriatumNeurophysiologyMedicinePsychopharmacologyNeuropharmacology	1985	108
5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates G.A. Ricaurte, L.E. DeLanney, Sandra G. Wiener, Brain Research Psychoactive Drug5-Hydroxyindoleacetic AcidNeurophysiologyNeuroanatomyMedicine	1988	89
Older dopaminergic neurons do not recover from the effects of MPTP G.A. Ricaurte, L.E. DeLanney, Ian Irwin, Neuropharmacology NeurophysiologyNeurotransmitterNeuropharmacologyOlder Dopaminergic NeuronsNeuroscience	1987	75
Electron microscopy of Lewy bodies in the amygdala-parahippocampal region. Comparison with inclusion bodies in the MPTP-treated squirrel monkey. Lysia S. Forno, L.E. DeLanney, Ian Irwin, PubMed Neurobiological MechanismMolecular NeuroscienceElectron MicroscopyBrain StructureNeurophysiology	1996	54
VII. The biotransformation of MPTP and disposition of MPP+: Tge effects of aging J. William Langston, Ian Irwin, L.E. DeLanney Life Sciences AgingBiochemistryLongevityMedicinePhysiology	1987	51

Page 1